About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT06665503

The Impact of Zinc and Probiotics in Preventing Pediatric Antibiotic-Associated Diarrhea in Southern Iran

The Impact of Zinc and Probiotics in Preventing Pediatric Antibiotic-Associated Diarrhea in Southern Iran

Lead sponsor: Hormozgan University of Medical Sciences•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Hormozgan University of Medical Sciences

The participants will be children aged 3 months to 3 years.The zinc group received oral zinc supplementation; 2.5 ml every 12 hours for children aged \<1 year and 5 ml every 12 hours for older children; the probiotics group received oral probiotics; 1 probiotic sachet; and the control group received nothing.

Age

0 - 3 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. children aged 3 months to 3 years
•2. prescribed antibiotics for various medical conditions

Exclusion Criteria

•1. Diarrhea, Dysentery
•2. Underlying chronic disease

Related studies

RECRUITINGPhase 3

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

NCT07087054 · Carcinoid Syndrome, Carcinoid, and more

RECRUITINGPhase 3

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

NCT06237452 · Clostridium Difficile, Clostridium Difficile Infections, and more

RECRUITINGPhase 1

KAN-004 for Immune-Related Diarrhea or Colitis

NCT07196410 · Colitis, Diarrhea Caused by Antitumor Drugs

Observational Study of Gut Microbiota in Abemaciclib-Treated Patients With and Without Diarrhea

NCT07264998 · Breast Neoplasms, Hormone Receptor-Positive Breast Cancer, and more

RECRUITINGPhase 1

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

NCT04038619 · Colitis, Diarrhea, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 12, 2024Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment165

Start dateSep 2020

Last updatedNov 12, 2024

Condition

Antibiotic-associated Diarrhea Diarrhea

Locations shown

Hormozgan University of Medical Sciences

Bandar Abbas, Hormozgan

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 12, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions